Note: Emerald Therapeutics's revenues are gauged from an analysis of company filings.
Emerald Therapeutics's Income Statement (based on Industry Averages)
Emerald Therapeutics P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Investor Activity
Emerald Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
February 21, 2014
5
93%
$6 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Emerald Therapeutics is developing and marketing.
Emerald Therapeutics's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SLL Recorded computer software, namely, software framework for planning, implementing, controlling, monitoring, analyzing, and reproducing laboratory experiments; Recorded computer software, namely, software for providing instructions for conducting customizable scientific experiments; Recorded computer program, namely, a function-based programming interface for use in controlling remote laboratory equipment
03/03/2023
ECL CONSTELLATION Cloud computing for remote medical laboratories featuring software for use in monitoring laboratory equipment and recording data; Cloud computing for remote scientific laboratories featuring software for use in monitoring laboratory equipment and recording data; Cloud computing for remote laboratory experiments on behalf of others featuring software for use in monitoring laboratory equipment and recording data; software as a service featuring software for use in data processing for remote laboratory experiments, for running remote laboratory experiments, for reviewing remote laboratory experiment controls, equipment, and environment data, and for reviewing remote laboratory experiment results; software as a service featuring software for use in data processing for computer simulations of remote laboratory experiments and for computer simulations of biological and chemical phenomena and systems; cloud computing featuring software for use in data processing for remote scientific testing of chemicals, pharmaceuticals, biologics, vaccines, and medical devices; cloud computing featuring software for use in data processing for biopharmaceutical research design and scientific testing services; cloud computing featuring software for use in data processing for product safety and quality assurance testing for pharmaceuticals, biopharmaceuticals, chemicals, medical devices, vaccines, and biologics; cloud computing featuring software for use in data processing for remote toxicological safety and quality assurance testing for pharmaceuticals, chemicals, and consumer products; cloud computing featuring software for use in indexing, storage, and searching of information relating to remote laboratory experiment controls, equipment, environment data, and experiment results as well as information relating to computer simulations of laboratory experiments and biological and chemical phenomena and systems; software as a service featuring software for creation and processing of un-structured, semi-structured, and structured information relating to laboratory experiments and computer simulations of laboratory experiments and biological and chemical phenomena and systems; software as a service featuring software for use in developing, executing, monitoring, and managing enterprise resource planning, manufacturing execution systems, and connected factories
03/18/2019
See all trademarks and details in the Full Report.
Market Share of Emerald Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Emerald Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Emerald Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Emerald Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.